# Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis

> **NCT07588672** · NA · NOT_YET_RECRUITING · sponsor: **Polyrizon Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis (SAR)
- Allergic Rhinitis

## Interventions

- **DEVICE:** PL-14 Allergy Blocker
- **DEVICE:** Ayr® Saline Nasal Mist

## Key facts

- **NCT ID:** NCT07588672
- **Lead sponsor:** Polyrizon Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2027-07-15
- **Final completion:** 2027-09-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07588672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07588672, "Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07588672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*